Ekaterina A. Volosnikova
Kol'tsovo, NVS 630559, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
How to Turn a Poisonous Plant into Medicine: Non-Polar Extracts of Rhododendron adamsii (Sagan Dalya) Are Free of Grayanotoxins and Inhibit the SARS-CoV-2 Main Protease.
Journal: Molecules (Basel, Switzerland)
Published: May 06, 2026
Cell-Based Luciferase Assay for Testing SARS-CoV-2 3CL Protease Inhibitors.
Journal: Biosensors
Published: March 25, 2026
A Naked Lyophilized mRNA Vaccine Against Seasonal Influenza, Administered by Jet Injection, Provides a Robust Response in Immunized Mice.
Journal: Vaccines
Published: November 14, 2025
Does the Chimerization Process Affect the Immunochemical Properties of WNV-Neutralizing Antibody 900?
Journal: International journal of molecular sciences
Published: October 31, 2025
Lipophilic Substances of the Leaves and Inflorescences of Centaurea scabiosa L.: Their Composition and Activity Against the Main Protease of SARS-CoV-2.
Journal: Molecules (Basel, Switzerland)
Published: October 23, 2025
Development of a Method for Producing Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Using Fusion Protein Technology.
Journal: Current issues in molecular biology
Published: July 31, 2025
Altai maral (Cervus elaphus sibiricus) chymosin structural characterization and modeling the enzyme interaction with the chymosin-sensitive regions of κ-caseins.
Journal: International journal of biological macromolecules
Published: July 06, 2025
Ursane hybrids with 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines and study of their inhibition of main SARS-CoV-2 protease.
Journal: Steroids
Published: March 25, 2025
The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2.
Journal: Antibodies (Basel, Switzerland)
Published: January 29, 2025
Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Hydrolyze Recombinant RBD and Nucleocapsid (N) Proteins.
Journal: Biomedicines
Published: March 20, 2024
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations.
Journal: Antibodies (Basel, Switzerland)
Published: September 28, 2023
Last Updated: 09/26/2026